CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
CONFIDENCE-AIbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06134180
NCT06134180N/ACompleted

An AI-Embedded Intervention to Promote Financial Wellbeing Among Latino Family Caregivers

Case Western Reserve University·interventional·Posted Nov 18, 2023·Updated Jul 30, 2025

In Brief

A clinical study evaluating CONFIDENCE-AI for Alzheimer Disease and 3 related conditions. Completed, enrolled 14 participants across 1 site.

Detailed Summary

The intervention being tested, CONFIDENCE-AI is a refined version of the original CONFIDENCE intervention made to reduce psychological financial strain and improve management of out-of-pocket care costs while increasing caregiver resourcefulness skills. Participants will be asked to participate in a 4-week intervention that includes participation in four, synchronous group-based Zoom sessions as well as between-session activities to apply learning. Participants will also receive tailored text message notifications from the NeuViCare AI-powered app via text and will be able to submit questions to the app to receive financial well-being information related to caregiving.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedNov 18, 2023
Enrollment StartMar 23, 2024
Primary CompletionApr 1, 2025
Study CompletionMay 19, 2025
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 2.6 years ago

Interventions

CONFIDENCE-AIbehavioral

Multicomponent psychoeducational intervention focused on financial wellbeing